Description: It is the purpose of this paper to present sample calculations which demonstrate one possible actuarial approach in making the required cost analysis and illustrative costs to reinsure life risks individually under present-day conditions.

Description: The presenters describe the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. Learn the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. Walk through sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: This seminar is designed to give life and annuity practitioners an in-depth view of the important topics and fundamentals of reinsurance, from the perspective of a U.S. life insurance company. Reinsurance industry experts will present on the various types of reinsurance, contract issues, financial implications and other considerations. Attendees will leave this seminar with a stronger understanding of life and annuity reinsurance, and current topics. Keep in mind this seminar is designed for participants with a moderate level of experience. Educational Objectives • Provide attendees with a stronger understanding of life and annuity reinsurance, and current topics • Give attendees an in-depth view of important topics and fundamentals of reinsurance

Description: In session 140 PD of the Washington Annual Meeting panelists discuss issues related to equity-indexed annuity EIA products. From the Record of the Society of Actuaries, Vol. 23, No. 3.

Description: This session from the 1983 SOA Hollywood, Florida Meeting reviews NAIC regulation of reinsurance, problems of reinsurance coverage on internal replacements and rewrites, a short Reinsurance Section business report and other current topics. From Record of Society of Actuaries Vol. 9, No. 4

Description: In calculations involving the distribution of total claims in a risk theory setting, several authors have found it desirable to approximate a risk-theoretic distribution by use of the incomplete gamma function. A recent paper evaluated an excess loss ratio premium by use of a gamma distribution whose first and second moments agreed with those of the risk-theoretic loss distribution. A discussion of that paper pointed out that a translated gamma distribution allowed one to make the approximate distribution agree with the risk-theoretic distribution as far as the first three moments are concerned. The method presented in this paper allows one to make as many moments of the approximate distribution as desired agree with those of the risk-theoretic loss distribution. From Transactions of Society of Actuaries 1966, Vol. 18, Pt. 1, No. 52.

Description: This presentation discusses a process for determining the minimum reinsurance retention level consistent with defined parameters. The conclusions reached were: 1. Under PDS dependence, optimal reinsurance strategy is multivariate stop loss form. 2. Explicit solutions could be derived in certain bivariate model. 3. Binding and unbinding constraints are equivalent. From Actuarial Research Clearing House, 2012, Vol. 1.

Description: It is the purpose of this paper to outline the reasoning behind the Catastrophic Accident Hazard and some of the details of a reinsurance arrangement with Lloyds of London for managing this risk. Paper is followed by 2 discussion papers

Description: From the 1960 Transactions Vol. 12 No. 32, this paper provides a comprehensive introduction to nonproportional reinsurance and its application in life and health insurance, and employee benefit plans. The author defines the various types of reinsurance and notes that to date nonproportional reinsurance has not been widely used in the U.S. for life insurance, and explores areas for possible application. Theoretical aspects such as formulas for premium determination are also discussed.